Birth prevalence of disorders detectable through newborn screening by race/ethnicity

被引:107
作者
Feuchtbaum, Lisa [1 ]
Carter, Jennifer [2 ]
Dowray, Sunaina [2 ]
Currier, Robert J. [1 ]
Lorey, Fred [1 ]
机构
[1] Calif Dept Publ Hlth, Genet Dis Screening Program, Richmond, CA USA
[2] Publ Hlth Fdn Enterprises, City Of Industry, CA USA
关键词
birth prevalence; disorders; newborn screening; race and ethnicity; SICKLE-CELL-DISEASE; CONGENITAL HYPOTHYROIDISM; CYSTIC-FIBROSIS; DEHYDROGENASE-DEFICIENCY; UNITED-STATES; POPULATION; CALIFORNIA; RACE; THALASSEMIA; ETHNICITY;
D O I
10.1038/gim.2012.76
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学];
摘要
Purpose: The purpose of this study was to describe the birth prevalence of genetic disorders among different racial/ethnic groups through population-based newborn screening data. Methods: Between 7 July 2005 and 6 July 2010 newborns in California were screened for selected metabolic, endocrine, hemoglobin, and cystic fibrosis disorders using a blood sample collected via heel stick. The race and ethnicity of each newborn was self-reported by the mother at the time of specimen collection. Results: Of 2,282,138 newborns screened, the overall disorder detection rate was 1 in 500 births. The disorder with the highest prevalence among all groups was primary congenital hypothyroidism (1 in 1,706 births). Birth prevalence for specific disorders varied widely among different racial/ethnic groups. Conclusion: The California newborn screening data offer a unique opportunity to explore the birth prevalence of many genetic disorders across a wide spectrum of racial/ethnicity classifications. The data demonstrate that racial/ethnic subgroups of the California newborn population have very different patterns of heritable disease expression. Determining the birth prevalence of these disorders in California is a first step to understanding the short-and long-term medical and treatment needs faced by affected communities, especially those groups that are impacted by more severe disorders.
引用
收藏
页码:937 / 945
页数:9
相关论文
共 41 条
[1]
[Anonymous], 2011, State and County QuickFacts 2010
[2]
[Anonymous], 1993, GeneReviews
[3]
Baumeister L, 2000, HEALTH SERV RES, V35, P869
[4]
Molecular genetic confirmatory testing from newborn screening samples for the common African-American, Asian Indian, southeast Asian, and Chinese β-thalassemia mutations [J].
Bhardwaj, U ;
Zhang, YH ;
Lorey, F ;
McCabe, LL ;
McCabe, ERB .
AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (04) :249-255
[5]
Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening [J].
Bobadilla, JL ;
Macek, M ;
Fine, JP ;
Farrell, PM .
HUMAN MUTATION, 2002, 19 (06) :575-606
[6]
Health Status and Healthcare Use in a National Sample of Children with Sickle Cell Disease [J].
Boulet, Sheree L. ;
Yanni, Emad A. ;
Creary, Melissa S. ;
Olney, Richard S. .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2010, 38 (04) :S528-S535
[7]
The importance of race and ethnic background in biomedical research and clinical practice [J].
Burchard, EG ;
Ziv, E ;
Coyle, N ;
Gomez, SL ;
Tang, H ;
Karter, AJ ;
Mountain, JL ;
Pérez-Stable, EJ ;
Sheppard, D ;
Risch, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) :1170-1175
[8]
California Department of Public Health GDB Newborn Screening Program, 2007, NEWBORN SCREENING NE, P15
[9]
Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders [J].
Colah, Roshan ;
Gorakshakar, Ajit ;
Nadkarni, Anita .
EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (01) :103-117
[10]
Cutiongco-de la Paz E. M., 2009, ACTA MED PHILIPP, V43, P32